Bioventix PLC (AIM:BVXP)

Bioventix Income Statement

Financials in millions GBP. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	13.12	13.61	12.82	11.72	10.93
Revenue Growth (YoY)	-3.61%	6.17%	9.36%	7.22%	5.98%
Cost of Revenue	1.2	0.93	0.83	0.71	0.82
Gross Profit	11.92	12.68	11.99	11.01	10.11
Selling, General & Admin	2.05	1.99	1.77	1.61	1.51
Other Operating Expenses	-0.04	0.1	0.19	0.13	0.52
Total Operating Expenses	2.01	2.1	1.95	1.74	2.03
Operating Income	9.9	10.58	10.03	9.27	8.09
Interest Income	0.19	0.2	0.1	0	0.03
Interest Expense	-	-	-	-0	-
Other Non-Operating Income (Expense)	-	-0.18	-	-	-
Total Non-Operating Income (Expense)	0.19	0.02	0.1	0	0.03
Pretax Income	10.1	10.6	10.13	9.28	8.12
Provision for Income Taxes	2.51	2.51	1.76	1.6	1.39
Net Income	7.58	8.1	8.37	7.67	6.73
Net Income to Common	7.58	8.1	8.37	7.67	6.73
Net Income Growth	-6.33%	-3.29%	9.10%	14.01%	-6.54%
Shares Outstanding (Basic)	5	5	5	5	5
Shares Outstanding (Diluted)	5	5	5	5	5
Shares Change (YoY)	-0.08%	0.14%	0.56%	-0.03%	0.76%
EPS (Basic)	1.45	1.55	1.61	1.47	1.29
EPS (Diluted)	1.43	1.53	1.58	1.46	1.28
EPS Growth	-6.26%	-3.42%	8.48%	14.04%	-7.24%
Free Cash Flow	7.01	8.33	7.79	7.55	6.08
Free Cash Flow Growth	-15.80%	6.88%	3.27%	24.16%	-17.24%
Free Cash Flow Per Share	1.32	1.57	1.47	1.43	1.15
Dividends Per Share	1.500	1.550	1.520	1.260	1.050
Dividend Growth	-3.23%	1.97%	20.64%	20.00%	19.32%
Gross Margin	90.86%	93.20%	93.54%	93.94%	92.52%
Operating Margin	75.51%	77.79%	78.29%	79.13%	73.99%
Profit Margin	57.83%	59.51%	65.33%	65.48%	61.58%
FCF Margin	53.47%	61.21%	60.80%	64.38%	55.60%
EBITDA	10	10.7	10.16	9.42	8.22
EBITDA Margin	76.22%	78.62%	79.29%	80.35%	75.23%
EBIT	9.9	10.58	10.03	9.27	8.09
EBIT Margin	75.51%	77.79%	78.29%	79.13%	73.99%
Effective Tax Rate	24.88%	23.64%	17.39%	17.29%	17.08%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.